A recent article in the World Allergy Organization Journal aims to discourage the use of prescription and over-the-counter diphenhydramine. Clinical teams from Johns Hopkins University School of Medicine and the Division of Allergy and Immunology, University of California, San Diego, argue that the first-generation antihistamine has risks and should no longer be widely prescribed or made available over-the-counter. There are safer and more effective second-generation alternatives like cetirizine, loratadine, and fexofenadine available that might be …
Read More